• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (GFO) LUTONIX 035 DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9004
Device Problems Off-Label Use (1494); Material Rupture (1546)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/27/2019
Event Type  malfunction  
Manufacturer Narrative
Analysis/device evaluation: upon receipt, visual inspection revealed a longitudinal rupture in the balloon material at the distal marker band extending approximately 22mm in length to the middle of the balloon.The distal and proximal ends of the longitudinal rupture were perpendicular to the length of the balloon, creating a wide "u" shape.The distal and proximal curves of the "u" are jagged in nature.Functional testing confirmed the balloon was not able to maintain pressure.A device history record review was not able to be performed, as the lot number was not provided by the user facility.Conclusion: returned product analysis was able to confirm a longitudinal rupture in the balloon material, which was unable to maintain pressure.Based on the information provided and analysis results, a definitive root cause was not able to be determined.It should be noted the in stent lesion in the common femoral artery, not an approved indication for use, was not predilated prior to inflating the lutonix dcb catheter and may have contributed to the event.
 
Event Description
It was reported a lutonix percutaneous transluminal drug coated balloon (dcb) dilatation catheter allegedly ruptured at 6 atmospheres (atms) while treating the in-stent target lesion of the distal left common iliac artery.The health care professional (hcp) used a contralateral approach to gain patient access.The hcp did not predilate the in-stent target lesion.The stent was intact and did not appear to be fractured.The hcp reportedly advanced the lutonix dcb to the target lesion in the zilver ptx stent, and inflated the balloon to 6 atms.After the lutonix dcb allegedly ruptured, reportedly it was removed in its entirety without difficulty.The hcp completed the procedure with another lutonix dcb.In the opinion of the hcp, the inflation within the zilver stent was related to the nature of the rupture.The lutonix dcb was returned for evaluation.No adverse patient outcomes were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035 DRUG COATED BALLOON PTA CATHETER
Type of Device
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
mike gaffney
9409 science center dr
new hope, MN 55428
7634458639
MDR Report Key8573861
MDR Text Key147096343
Report Number3006513822-2019-00065
Device Sequence Number1
Product Code ONU
UDI-Device Identifier00801741123252
UDI-Public(01)00801741123252
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P130024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 05/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9004
Device Catalogue NumberLX351306405F
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/25/2019
Is the Reporter a Health Professional? Yes
Event Location Hospital
Initial Date Manufacturer Received 04/03/2019
Initial Date FDA Received05/02/2019
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age87 YR
Patient Weight61
-
-